Listed

Cadre Holdings, Inc.

CDRENYSECIK 1860543HealthcareFiscal year ends Dec 31

Reports and events: 89 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Cadre Holdings, Inc., Reports and events
FiledFormWhat it isAccession number
2026-09-3019:47 ETSCHEDULE 13D/AOwnership report, active investor, amended0001104659-26-112476
2026-08-0716:15 ET8-K/A2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-092721
2026-08-0516:28 ET10-QQuarterly reportPeriod 2026-06-300001104659-26-091151
2026-08-0516:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-091143
2026-07-2916:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-26-088148
2026-06-1816:20 ETSCHEDULE 13D/AOwnership report, active investor, amended0001104659-26-075751
2026-06-0316:15 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001104659-26-070114
2026-05-1116:18 ET10-QQuarterly reportPeriod 2026-03-310001104659-26-058670
2026-05-1116:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-058660
2026-04-2408:30 ETDEF 14AProxy statementPeriod 2026-05-290001104659-26-048191
2026-03-1016:19 ET10-KAnnual reportPeriod 2025-12-310001104659-26-025862
2026-03-1016:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-025848
2026-02-0208:30 ET8-K/A1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-26-008994
2025-11-1916:15 ETSCHEDULE 13D/AOwnership report, active investor, amended0001104659-25-114105
2025-11-1416:15 ETSCHEDULE 13DOwnership report, active investor0001104659-25-112538
2025-11-0416:17 ET10-QQuarterly reportPeriod 2025-09-300001104659-25-106299
2025-11-0416:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-25-106290
2025-11-0316:16 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-25-105558
2025-10-2908:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-25-103556
2025-10-0808:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-25-097750
2025-08-0516:16 ET10-QQuarterly reportPeriod 2025-06-300001558370-25-010299
2025-08-0516:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-25-010294
2025-06-0516:47 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-25-056881
2025-05-0616:17 ET10-QQuarterly reportPeriod 2025-03-310001558370-25-006502
2025-05-0616:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-25-006500
2025-04-2416:15 ETDEF 14AProxy statementPeriod 2025-05-300001104659-25-038649
2025-03-1116:18 ET10-KAnnual reportPeriod 2024-12-310001558370-25-002711
2025-03-1116:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-25-002709
2025-01-2716:16 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-25-006329
2025-01-2116:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-25-004898
2025-01-1607:44 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-25-003946
2025-01-1516:15 ET8-K5.02 Departure or appointment of officers or directors0001104659-25-003767
2024-12-2316:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-24-131303
2024-11-0816:15 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-24-115878
2024-11-0616:20 ET10-QQuarterly reportPeriod 2024-09-300001558370-24-014638
2024-11-0616:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-24-014629
2024-08-0916:17 ET10-QQuarterly reportPeriod 2024-06-300001558370-24-011750
2024-08-0916:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-24-011748
2024-07-1916:19 ET8-K8.01 Other events0001104659-24-081176
2024-06-0416:21 ET8-K5.07 Shareholder vote results0001104659-24-068258
2024-05-0816:16 ET10-QQuarterly reportPeriod 2024-03-310001558370-24-007349
2024-05-0716:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-24-007054
2024-04-2916:15 ETDEF 14AProxy statementPeriod 2024-05-310001104659-24-054037
2024-03-1916:16 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-24-036150
2024-03-1216:32 ET10-KAnnual reportPeriod 2023-12-310001558370-24-002995
2024-03-0616:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-24-031464
2024-03-0516:17 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-24-002481
2024-02-2316:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-24-027033
2024-02-2016:37 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-24-025573
2023-12-2916:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-23-130479

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.